Literature DB >> 3567525

The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates.

L F Torres, L W Duchen.   

Abstract

The mdx mutant mouse was first observed during a survey of genetic variations of pyruvate kinase in the mouse. Affected mice have high serum levels of this enzyme and although showing little disability they have widespread and severe muscle disease. Light and electron microscopy, muscle enzyme histochemistry and combined cholinesterase-silver impregnations were used for the study of affected and control animals aged 1 day to 1 year. An early ultrastructural abnormality present already at 1 day was scattered focal streaming of Z-lines. Later there was also segmental muscle fibre necrosis and regeneration. The proportion of muscle fibres showing either necrosis, regeneration or internal nuclei was assessed in several muscles, at ages ranging from 10 days to 1 year. Acute segmental necrosis and regeneration were most marked at 1 to 2 months, although they were present at all ages. The number of fibres with internal nuclei increased progressively until 3 months when 70-80% showed this abnormality. Nerve terminals were unaffected but there was a reduction in the number and depth of postsynaptic folds at motor end-plates in adult animals, confirmed by morphometric analysis. Quantitative study of L4 motor root and tibial nerve showed that fibre numbers, axonal calibres and myelin sheath thickness were normal at all ages. No qualitative abnormalities were found in the CNS or other organs. The findings strongly suggest that the mdx mutant has a primary muscle disease and that the nervous system is normal.

Entities:  

Mesh:

Year:  1987        PMID: 3567525     DOI: 10.1093/brain/110.2.269

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  97 in total

Review 1.  Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.

Authors:  Kyung-Hye Huh; Christian Fuhrer
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

2.  β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice.

Authors:  Jianming Liu; Derek J Milner; Marni D Boppart; Robert S Ross; Stephen J Kaufman
Journal:  Hum Mol Genet       Date:  2011-12-16       Impact factor: 6.150

3.  Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice.

Authors:  Y Tang; D P Reay; M N Salay; M Y Mi; P R Clemens; D C Guttridge; P D Robbins; J Huard; B Wang
Journal:  Gene Ther       Date:  2010-08-19       Impact factor: 5.250

4.  Cardiac syntrophin isoforms: species-dependent expression, association with dystrophin complex and subcellular localization.

Authors:  Yuko Iwata; Munekazu Shigekawa; Shigeo Wakabayashi
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

5.  Truncated dystrophins can influence neuromuscular synapse structure.

Authors:  Glen B Banks; Jeffrey S Chamberlain; Stanley C Froehner
Journal:  Mol Cell Neurosci       Date:  2009-01-08       Impact factor: 4.314

6.  Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.

Authors:  Christian Isaac; Adam Wright; Arvydas Usas; Hongshuai Li; Ying Tang; Xiaodong Mu; Nicholas Greco; Qing Dong; Nam Vo; James Kang; Bing Wang; Johnny Huard
Journal:  J Orthop Res       Date:  2012-10-23       Impact factor: 3.494

7.  Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the pathogenesis of Duchenne muscular dystrophy.

Authors:  Adriana Pertille; Candida Luiza Tonizza de Carvalho; Cintia Yuri Matsumura; Humberto Santo Neto; Maria Julia Marques
Journal:  Int J Exp Pathol       Date:  2009-12-03       Impact factor: 1.925

8.  Ca2+ levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice.

Authors:  A J Bakker; S I Head; D A Williams; D G Stephenson
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

9.  Dystrophin As a Molecular Shock Absorber.

Authors:  Shimin Le; Miao Yu; Ladislav Hovan; Zhihai Zhao; James Ervasti; Jie Yan
Journal:  ACS Nano       Date:  2018-11-27       Impact factor: 15.881

10.  Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

Authors:  Christine Péladeau; Aatika Ahmed; Adel Amirouche; Tara E Crawford Parks; Lucas M Bronicki; Vladimir Ljubicic; Jean-Marc Renaud; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.